Abstract:OBJECTIVE:To investigate the treatment status of antiparkinsonism in Xi'an.METHODS:Six general hospitals were randomly chosen in Xi'an and all Parkinson's disease (PD) patients were interviewed by questionnaire from Jan. 2007 to Apr. 2007.RESULTS:92 PD outpatients were enrolled in, including 48 males and 44 females, from 43 to 86 years old (mean 65.6 +/- 17.1) with duration of the disease from 0.2 to 27.8 years (mean 4.4 +/- 9.4). The preference of the drug use from the patients were: 40 (43.5%) preferred taking levodopa, 25 (27.2%) with amantadine and/or trihexyphenidyl, 14 (15.2%) with levodopa and others, 4 (4.4%) with dopamine agonist and others, 2 (2.2%) with other drugs, 7 (7.6%) with no treatment. There were 69 (75.0%) patients onset with resting tremor, 15 (16.3%) with bradykinesia, 6 (6.5%) with rigidity, and 2 (2.2%) with unknown symptoms. There was no startically significant difference in anti-PD drugs among the patients onset with different symptoms (P > 0.05). 45 patients appeared the onset of disease before 65 years old and with no dementia, 47 onset after 65 with or without dementia. There was no significant difference of anti-PD drugs between the two groups (P > 0.05). Most patients initiated anti-PD treatment with levodopa but few of them chose dopamine agonist. According to the classification of Hoehn & Yahr, 25(27.2%)belonged to Grade I, 53 (57.6%) to Grade II, 8 (8.7%) to Grade III, 3 (3.3%) to Grade IV and 3 (3.3%) to Grade V. There was no significant differences of anti-PD drugs between different grades of the disease (P > 0.05). 55.3% of the patients changed their anti-PD drugs randomly during the therapy, but with no relation to their gender, age, educational level, dementia, the number of family members, course of diseases, or the degree of Hoehn & Yahr, frequency and categories of medicine.CONCLUSION:Anti-PD treatment in Xi'an did not strictly follow the standardized protocol, with few patients using dopamine agonist and over 50% of the patients changed their drugs randomly.

The Epidemiology of Parkinson Disease among Elderly People in Xi'an , China

Parkinson's Disease in China: Prevalence in Beijing, Xian, and Shanghai

Prevalence of Parkinson's disease among adults aged 45 years and older in China: a cross-sectional study based on the China health and retirement longitudinal study

The Nutritional Status of Elderly Chinese Patients with Parkinson’s Disease

Prevalence of Parkinson's Disease: A Community‐Based Study in China

Study of the prevalence of senile dementia among elderly people in Xi'an, China

The Incidence of Dementia among Elderly People in Xi’an,China

Prevalence of Alzheimer's Disease and Parkinson's Disease in China: An Updated Systematical Analysis

The Prevalence of Parkinson's Disease Continues to Rise after 80 Years of Age: a Cross-Sectional Study of Chinese Veterans.

Parkinson's Disease Research in a Prospective Cohort in China

The Use of Antiparkinsonism Drugs in 92 Cases in Xi' an City

Analysis of the Prevalence and Risk Factors for Parkinson's Disease in middle-aged and Elderly Residents of Aerospace Center Hospital Adjacent Communities

Investigating the Prevalence of Dementia and Its Associated Risk Factors in a Chinese Nursing Home

A clinical study on the cognitive impairment in patients with Parkinson's disease among natural population aged 55 years old and older

Analysis of mortality in Parkinson disease in China: Exploration of recent and future trends

Prevalence Swrvey of Dementia among Elderly in a Urban Community in Shanghai

Clinical Profile of Parkinson's Disease in the Gumei Community of Minhang District, Shanghai.

Incidence of Senile Dementia and Depression in Elderly Population in Xicheng District, Beijing, an Epidemiologic Study

Parkinson’s Disease in China: a Forty-Year Growing Track of Bedside Work

A cross-sectional study of sleep disorder among elderly population in urban community in Hebei Province

[Study on the status of cognition among Parkinson's disease patients in Xi'an.].